Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Catalina Coclitu, Cris S. Constantinescu & Radu Tanasescu. (2016) The future of multiple sclerosis treatments. Expert Review of Neurotherapeutics 16:12, pages 1341-1356.
Read now
Read now
James P Sheridan, Randy R Robinson & John W Rose. (2014) Daclizumab, an IL-2 modulating antibody for treatment of multiple sclerosis. Expert Review of Clinical Pharmacology 7:1, pages 9-19.
Read now
Read now
Articles from other publishers (16)
Gauruv Bose, Harold L Atkins, Marjorie Bowman & Mark S Freedman. (2018) Autologous hematopoietic stem cell transplantation improves fatigue in multiple sclerosis. Multiple Sclerosis Journal 25:13, pages 1764-1772.
Crossref
Crossref
Ekaterina Eremenko, Kritika Mittal, Omer Berner, Nikita Kamenetsky, Anna Nemirovsky, Yehezqel Elyahu & Alon Monsonego. (2019) BDNF-producing, amyloid β-specific CD4 T cells as targeted drug-delivery vehicles in Alzheimer's disease. EBioMedicine 43, pages 424-434.
Crossref
Crossref
Forouzan Yousefi, Fahimeh Lavi Arab, Kolsoum Saeidi, Houshang Amiri & Mahmoud Mahmoudi. (2019) Various strategies to improve efficacy of stem cell transplantation in multiple sclerosis: Focus on mesenchymal stem cells and neuroprotection. Journal of Neuroimmunology 328, pages 20-34.
Crossref
Crossref
Muhibullah S. Tora, Kelly M. Poth, Nathan Hardcastle, Kaitlin Sandor, Casey Anthony, Long Di & Nicholas M. Boulis. 2019. Nervous System Drug Delivery. Nervous System Drug Delivery
133
161
.
Mehrdad Gholamzad, Masoumeh Ebtekar, Mehdi Shafiee Ardestani, Maryam Azimi, Zeinab Mahmodi, Mohammad Javad Mousavi & Saeed Aslani. (2018) A comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future. Inflammation Research 68:1, pages 25-38.
Crossref
Crossref
Dimitrios Karussis & Panayiota Petrou. (2018) Immune reconstitution therapy (IRT) in multiple sclerosis: the rationale. Immunologic Research 66:6, pages 642-648.
Crossref
Crossref
Noga Or-Geva & Yair Reisner. 2018. Haploidentical Transplantation. Haploidentical Transplantation
15
28
.
Dimitrios Karussis. 2017. International Encyclopedia of Public Health. International Encyclopedia of Public Health
145
179
.
Katherine Buzzard, Wing Hei Chan, Trevor Kilpatrick & Simon Murray. 2017. Neurodegenerative Diseases. Neurodegenerative Diseases
211
252
.
Ellen M Mowry. (2016) Haematopoietic stem cell transplants should be a second-line therapy for highly active MS – Commentary. Multiple Sclerosis Journal 22:10, pages 1263-1265.
Crossref
Crossref
J. E. Vaughn, F. Anwer & H. J. Deeg. (2016) Treatment of refractory ITP and Evans syndrome by haematopoietic cell transplantation: is it indicated, and for whom?. Vox Sanguinis 110:1, pages 5-11.
Crossref
Crossref
I. Kassis, P. Petrou & D. Karussis. 2016. Translational Neuroimmunology in Multiple Sclerosis. Translational Neuroimmunology in Multiple Sclerosis
441
456
.
N Or-Geva & Y Reisner. (2015) The role of donor-derived veto cells in nonmyeloablative haploidentical HSCT. Bone Marrow Transplantation 50:S2, pages S14-S20.
Crossref
Crossref
M. V. Robinson, E. V. Mel’nikova & V. A. Trufakin. (2015) Effect of Diprotin A, an Inhibitor of Dipeptidyl Peptidase IV, on Immunological Parameters of Lymphocytes in Intact Animals and Animals with Experimental Autoimmune Process. Bulletin of Experimental Biology and Medicine 158:6, pages 769-771.
Crossref
Crossref
A.-L. Dubessy, V. Zujovic, C. Papeix & B. Stankoff. (2014) Biotherapies in multiple sclerosis: A step toward remyelination and neuroprotection?. Revue Neurologique 170:12, pages 770-778.
Crossref
Crossref
Ike De La Pena, Mibel Pabon, Sandra Acosta, Paul R. Sanberg, Naoki Tajiri, Yuji Kaneko & Cesar V. Borlongan. (2014) Oligodendrocytes Engineered with Migratory Proteins as Effective Graft Source for Cell Transplantation in Multiple Sclerosis. Cell Medicine 6:3, pages 123-127.
Crossref
Crossref